Cumberland Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid
Cumberland Pharmaceuticals Inc. (CPIX) had Lessee, Operating Lease, Liability, to be Paid of $6.98 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-08-07
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid $6.98M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $7.21M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $7.43M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $7.61M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-06-30 | $6.98M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $7.21M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $7.43M 10-K · filed 2026-03-09 |
| 2025-09-30 | $7.61M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $7.83M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $8.05M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $8.27M 10-K · filed 2025-03-07 |
| 2024-09-30 | $8.49M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $8.70M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $8.92M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $9.13M 10-K · filed 2024-03-13 |
| 2023-09-30 | $9.34M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.55M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.26M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $8.43M 10-K · filed 2023-03-13 |
| 2022-09-30 | $243.01K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $533.49K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $823.31K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.11M 10-K · filed 2022-03-11 |
| 2021-09-30 | $1.41M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.69M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.97M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $2.26M 10-K · filed 2021-03-12 |
| 2020-09-30 | $2.55M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.82M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.10M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $3.38M 8-K · filed 2020-12-10 |
| 2019-09-30 | $3.66M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.91M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.20M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |